An Analysis of Efficacy Data from Four Phase III Studies of Botulinum Neurotoxin Type A-ABO for the Treatment of Glabellar Lines

BoNTA-ABO significantly improved moderate to severe glabellar lines compared with placebo, with onset of effect seen as soon as 24 hours after treatment and a median duration of effect of 85 and 109 days for fixed and variable dosing, respectively.